Memiontec Holdings Ltd. Overview
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Employee wages and benefits (S$ M) | 6.6 | 7.6 | 9.4 | 0 |
Note: the FY2025 figure is shown as 0 only because the Group did not publish the economic-value-distributed table in the AR2025 extract reviewed; treat FY2025 as not publicly disclosed. G&A payroll costs were S$1.89M in FY2024 and S$1.58M in FY2025 (FY2025 results), and fell a further 37.5% year on year in 1H2026.
Memiontec is a Singapore-headquartered, founder-controlled micro-cap water engineering group that designs, builds, operates and, in Indonesia, co-owns water and wastewater treatment assets. The company built its reputation as a membrane and MEICA (Mechanical, Electrical, Instrumentation, Control and Automation) contractor to Singapore's national water agency PUB, delivering packages at Tuas South Desalination Plant, Kranji NEWater, Changi Water Reclamation Plant Phase 2 and the Deep Tunnel Sewerage System Phase 2. In Indonesia it combines EPC work with minority and majority equity stakes in five BOOT/TOOT concessions, partnered with state-linked entities such as Jakarta Propertindo, PT PP Infrastruktur and ITDC. The business peaked at S$66.9M revenue in FY2023, then fell into consecutive losses as fixed-price PUB contracts suffered prolonged construction and cost overruns. With S$2.8M of attributable equity at 30 June 2026, covenant waivers in place and reliance on CEO loans, Memiontec is now a balance-sheet repair and recurring-income transition story rather than a growth story.
Company's own description
In its Annual Report 2025, Memiontec describes itself as a one-stop water technology total solutions provider with more than 30 years in the water industry. It combines membrane filtration, ion exchange, and physical, chemical and biological treatment processes with in-house design, customised engineering and turnkey implementation. It states a presence in Singapore, Indonesia, China and Vietnam, serving both municipal and industrial customers. The company also says it creates shareholder value through long-term BOOT (Build-Own-Operate-Transfer) and TOOT (Transfer-Own-Operate-Transfer) investments that generate recurring income (AR2025, "About Us").
Business model and revenue model
The Group reports four segments that together span the water value chain:
-
TSEPC (Total Solutions with Engineering, Procurement and Construction) is project-based, fixed-price contracting, with revenue recognised over time by stage of completion. It accounted for 83.8% of FY2025 revenue and 93.9% of FY2024 revenue (AR2025 Operating and Financial Review).
-
OMS (Operations, Maintenance and Services) is service revenue recognised over time. Contracts typically run 1–3 years. OMS on the Group's BOOT/TOOT concessions runs 20–25 years (AR2025 Synergistic Business Model).
-
SDS (Sales and Distribution of Systems and Equipment, including trading) is product revenue recognised at a point in time. It covers modular systems, components, chemicals and membranes, including products sold as an authorised distributor.
-
SOW (Sales of Water) is recurring, concession-style revenue from BOOT/TOOT projects where the Group is owner or co-owner. It is recognised at a point in time. A material part of the economic value sits outside consolidated revenue because several concessions are equity-accounted JVs or FVOCI investments.
Revenue mix by nature, FY2025 (S$'000, FY2025 results announcement): project/service revenue recognised over time was 23,260 (TSEPC 21,753 + OMS 1,507), or 89.6%. Product and water revenue recognised at a point in time was 2,688 (SDS 2,230 + SOW 458), or 10.4%. The company has no subscription or licensing revenue.
Value-chain position
Memiontec sits in the midstream of the water value chain. It buys membranes, pumps, piping, instrumentation and civil/M&E subcontract services, adds in-house process design, PLC/control engineering and fabrication, and delivers turnkey plants. Downstream, it captures operating income through OMS and, in Indonesia, tariff-type income through concessions. It owns no membrane manufacturing IP. Its differentiation rests on process design know-how, licensing (BCA ME11 Grade L6 in Singapore; B1/B2 construction licences in Indonesia), and long-standing relationships with PUB and Indonesian state-linked partners (AR2024 Chairman and CEO's Message).
Customer types and end-markets
Singapore public sector: PUB is the dominant Singapore customer. Named projects include the C22C MBR contract at Changi WRP Phase 2 (S$56.6M), DTSS Phase 2 odour control and air jumper facilities (S$21.7M), Tuas South Desalination Plant ultrafiltration (S$33.2M), and Jurong Island STP M&E replacement.
Singapore other institutional: Mandai Wildlife (penguin exhibit and bird park life-support systems) and Semakau Landfill (NEA-related floating wastewater treatment and power generation system).
Indonesian municipal: city water and sewerage agencies (Palembang, Makassar, Jambi, Pekanbaru, Jakarta via PAM Jaya/Jakpro) and the tourism-estate utility ITDC (Nusa Dua, Bali).
Indonesian industrial: agro-industry and palm oil (Dumai, WPS biodiesel effluent), food and beverage (Indolakto), mining (Amman Mineral townsite RO; Adaro intake relocation), and industrial estates (Suryacipta).
China: trading of components through MIT Water Technology (Chengdu). Revenue is negligible (S$11k in FY2023; nil in FY2024–FY2025).
Vietnam: a subsidiary was incorporated in October 2022 for construction of water supply and drainage systems. No disclosed revenue to date.
Independent characterisation
Memiontec is best understood as a sub-scale, founder-run specialty water contractor whose earnings are dominated by a small number of large, lumpy, fixed-price public tenders in Singapore. It also has a slower-burn Indonesian portfolio of co-owned concessions. The Singapore franchise is technically credible: the Group is one of the few local SMEs with unlimited-value ME11 L6 registration. However, the FY2024–FY2025 losses show that the Group carried construction-period and cost-escalation risk it could not pass through. The C22C and DTSS2 contracts, won in 2021–2022, absorbed post-pandemic labour, material and financing inflation. Indonesia has been the steadier contributor, but it generates modest absolute profits, carries IDR translation risk, and relies on contractual "Combination Agreements" rather than direct equity ownership for control of PT Memindo Pratama. The investment case now hinges on (i) collection of final accounts and certification of unrecognised variation orders on the Singapore projects, (ii) commercial operation of the Bali desalination BOOT and Tanah Merah BOOT, and (iii) whether the balance sheet can be stabilised without further heavy dilution.
Strategy
Stated strategy (themes from AR2024 and AR2025)
-
Recurring income through concessions. The Group aims to grow recurring income from BOOT/TOOT service-concession projects in Asia, positioning itself as owner or co-owner rather than pure contractor. It is currently co-owner in five Indonesian projects.
-
Scale up project size in Indonesia by partnering with local and overseas companies for larger EPC tenders in government and private industrial sectors, and by bidding for new BOOT projects.
-
Disciplined Singapore tendering. The Group continues to tender for PUB and private membrane and MEICA work, but AR2025 and the 1H2026 commentary put greater emphasis on project risk assessment, commercial viability, contract terms and expected returns.
-
SDS expansion. This includes broadening distribution channels, securing regional distribution rights, scaling the Memiontec-brand standard systems, and integrating PRC sourcing to reduce cost of goods.
-
Regional expansion into Vietnam (50-year water concession models cited) and Cambodia through investment, JV and partnership.
-
Funding and M&A. AR2024 lists fundraising, strategic investors and M&A as strategic levers, and mentions tapping Indonesia's capital market through the PT MIT Investment Indonesia structure.
-
Liquidity first (AR2025). Management now prioritises cash-flow management, working-capital discipline, collection of final accounts and VO claims, and both equity and debt fundraising.
Initiatives announced in the last 24 months
| Date | Initiative | Detail | Status |
|---|---|---|---|
| Oct 2024 | Minority stake in PT Tirta Mitra Abadi | Vehicle for new BOOT/TOOT tendering | Ongoing; no project announced |
| 2,024 | PTMP office expansion; larger SDS sales team | Supports Indonesian SDS growth and PRC supply-chain integration | Completed |
| Dec 2024 – May 2025 | Rights cum warrants issue | 440.5M rights shares at S$0.009; 704.8M warrants at S$0.003 (exercise could add ≈S$2.1M if fully exercised) | Completed; 44.8M warrants exercised by 30 Jun 2026 |
| Apr 2025 | Finance leadership succession | CFO role replaced by a Financial Controller; former CFO moved to non-executive board seat | Completed |
| 2,025 | Bali BOOT testing and commissioning water sales | SOW revenue S$458k in FY2025; S$631k in 1H2026 | Commercial operation date not yet announced |
| 2,025 | Tanah Merah BOOT construction completed | 42% stake | Operating status and COD not separately announced |
| 2025–2026 | VO claims on Singapore projects | Submitted; not recognised in accounts or cash-flow projections | Pending certification |
| 2025–2026 | Cost programme | Lower headcount, dormitory and overhead costs; G&A −27.8% in 1H2026 | Ongoing; no quantified target |
| 1H2026 | Lender negotiations | One-off covenant waivers; scheduled debt reduction | Ongoing |
ESG commitments and targets (AR2025)
-
Execute or complete at least three TSEPC projects in municipal and industrial sectors (FY2026 target; met in FY2024).
-
Maintain at least 50% of procurement with local suppliers (FY2026), rising to at least 90% beyond 2030. Achieved 95.6% in FY2025.
-
No significant operational disruptions from adverse climate conditions (met in FY2025).
-
Monitor Scope 1 and 2 emissions; collect Scope 3 data by 2030; progressively align with TCFD and prepare for ISSB (IFRS S1/S2).
Medium-term financial targets / guidance
None disclosed. The Group publishes no revenue, margin or return targets. Its only forward-looking statements are qualitative (order book completion within two years; VO certification; continued tendering).
Products & Services
Memiontec does not publish a priced product catalogue. The table below lists every product line, solution type and flagship reference project in its annual reports and contract announcements. Pricing is not publicly disclosed for any line. TSEPC is priced by tender or lump-sum contract, OMS by service contract, SDS by unit sale, and SOW by concession tariff (tariffs not disclosed).
TSEPC — solution lines
| Solution line | Description / technologies | Target customers | Flagship references (capacity; status) | Source |
|---|---|---|---|---|
| Water treatment plants | Clarification, gravity filtration, UF, RO; potable and process water | Municipal water agencies; industrial estates; mining townsites | Oloboju WTP rehabilitation (300 L/s, Indonesia); Suryacipta industrial WTP (5,000 m³/day); Amman townsite RO WTP (1,500 m³/day); Tarjun WTP upgrade (to 250 m³/hour); IKK MEIA installation (120,000 m³/day) | AR2025 project portfolio |
| Wastewater / water reclamation | MBR, MBBR, aerobic reactors, anaerobic treatment, UV, sand and carbon filtration, high-rate clarification | Municipal sewerage; F&B; palm oil and biodiesel | Changi WRP Phase 2 C22C MBR (22 MGD; ~1,736 L/s per AR; S$56.6M; Phase A substantially completed 2025); Jurong WRP MBR (787 L/s); Changi WRP high-rate clarification (2,300 L/s); Palembang STP (230 L/s); Makassar WWTP (185 L/s); Jambi WWTP (88 L/s); Indolakto WWTP (MBBR/UF/RO, 10 L/s); WPS biodiesel effluent (50 m³/day, anaerobic); FOI WWTP upgrade (300→600 m³/day) | AR2025; C22C announcement (24 Mar 2022) |
| Water recycling (NEWater) | Pressurised microfiltration, RO membranes | PUB | Kranji NEWater Factory: RO (900 L/s), MF (1,193 L/s), pressurised MF and RO (266 L/s) | AR2025 |
| Seawater desalination | UF pre-treatment, SWRO, polishing | PUB; tourism estates | Tuas South Desalination Plant UF (8,800 L/s; S$33.2M; completed 2021); Nusa Dua SWRO BOOT (10,000 m³/day per contract announcement) | AR2025; Bali announcement (24 Oct 2023) |
| Disinfection | Electrochlorination; chlorine contact tanks | PUB | Bedok Waterworks electrochlorination and chlorine contact tank (1,578 L/s each) | AR2025 |
| Odour control / sewer MEICA | Odour control and air jumper facilities; MEICA works | PUB | DTSS Phase 2 Odour Control & Air Jumper Facilities (S$21.7M; substantially completed 2025) | SGXNet (Apr 2021); AR2025 |
| M&E replacement | Mechanical and electrical equipment replacement | PUB | Jurong Island Sewage Treatment Plants 1 & 2 | The Edge (Aug 2021); AR2025 |
| Specialty systems | Animal life-support systems; floating WTP with power generation | Zoological parks; landfill | Mandai penguin exhibit life support (388 L/s); Mandai Bird Park life support (2018); Semakau Landfill WWTP and power generation (208 L/s) | AR2025 |
| Pipeline and intake works | HDPE transmission pipelines | Municipal/mining | IKK intake pipeline (8 km); Adaro intake relocation (8 km HDPE) | AR2025 |
| Plantation WTP/WWTP | Design-build water and wastewater plants | Plantations | Dumai WTP (350 m³/day) and WWTP (590 m³/day) | AR2025 |
| PAM Jaya water treatment | MBBR and UF | Jakarta water utility | PAM Jaya WTP (10 L/s); PAM Jaya Mookervaart WTP at Daan Mogot | AR2025; AGM 2021 slides |
OMS — service lines
| Service | Description | Contract tenor | Source |
|---|---|---|---|
| Plant operations | Operation of municipal/industrial plants, including concession plants | 1–3 years (standard); 20–25 years (concessions) | AR2025 |
| Preventive and corrective maintenance | Scheduled and breakdown maintenance of MEICA and membrane systems | 1–3 years | FY2025 results note 10 |
| Technical support and consultation | Process optimisation, troubleshooting | Ad hoc | AR2025 |
| Interim care and maintenance | e.g. DTSS2 MEICA equipment during the interim period | Project-linked | The Edge (Apr 2021) |
| Data-driven optimisation | PLC-based data collection from OMS and concession plants to lower operating cost | Embedded | AR2024 |
SDS — product lines
| Product line | Description | Source |
|---|---|---|
| Standard Memiontec-brand systems | Standardised treatment units sold under the Memiontec brand; two registered trademarks (IPOS Class 7, Feb 2023–Apr 2033; Class 11, Mar 2024–Sep 2034) | AR2024; AR2025 certification table |
| Modular and customised systems | Skid-mounted water treatment facilities | AR2025 |
| Containerised desalination plants | Mobile/containerised RO units | AR2025 |
| Water treatment equipment and components | Pumps, valves, instrumentation, spare parts | AR2025 |
| Chemicals | Specialty and blended treatment chemicals | Roic.ai profile; AR2025 |
| Membranes and media | Sold as an authorised distributor (principal brands not disclosed in sources reviewed) | Roic.ai profile |
| PRC-sourced components | Procurement and trading via MIT Water (Chengdu), integrated into Indonesian SDS supply chain | AR2024 |
SOW — concession assets (BOOT/TOOT)
| Project | Type | Location | Memiontec interest (partner) | Capacity | Concession | Status | Accounting |
|---|---|---|---|---|---|---|---|
| Hutan Kota | BOOT | Jakarta | 40% via PT Jakpro Memiontec Air (PT JUP 60%) | 500 L/s (43,200 m³/day) per AR2025; FY2022 results cite a 450 L/s design capacity at Phase 2 — discrepancy | 20+5 years from 2019 | Operating since Dec 2019 | Equity-accounted JV |
| Waduk Pluit | TOOT | Jakarta | 40% via KSO JUP MIT (PT JUP 60%) | Up to 2,500 m³/day | 25 years from 2018 | Operating since 2018 | Joint operation |
| Pekanbaru | BOOT | Riau | 15% in PT PP Tirta Madani (PT PP 85%) | Up to 750 L/s | 25 years | Phase 1 upgrading completed 2022 | FVOCI financial asset (S$2.05M at 30 Jun 2026) |
| Tanah Merah | BOOT | Jakarta | 42% in PT PP Tirta Tanah Merah (PT PP 51%, PT KCP 7%) | 200 L/s per AR2025 (the Sep 2023 announcement says "200 litres per day," apparently a typographical error) | 20 years from commercial operation date | Construction completed 2025 | Shown as a JV in the corporate structure chart |
| Nusa Dua, Bali | BOOT | Bali | 80% via KSO Memiontec–BSBK / PT Memiontec Bakti Bali (PT Bayu Surya Bakti Konstruksi 20%) | 10,000 m³/day per contract announcement; AR2025 shows 46 L/s (≈3,974 m³/day) — likely an initial phase; discrepancy unresolved | At least 15 years (AR); 25 years of water sales cited in milestones | Construction in progress; water sold during testing and commissioning since 2H2025 | Consolidated (SOW revenue; contract assets) |
Financial Narrative
All figures are audited unless stated otherwise. FY2021–FY2024 are audited figures as re-presented in subsequent announcements and Annual Reports 2024/2025. FY2025 balance sheet and P&L are per the unaudited FY2025 announcement (28 Feb 2026), confirmed as unchanged by the audited 31 Dec 2025 comparatives in the 1H2026 results and the AR2025 five-year summary.
Income statement: notes and sources
Sources: FY2022 results (FY2021 audited); FY2023 results (FY2022 audited comparatives — note the unaudited FY2022 announcement had shown operating profit of S$3,538k and net profit of S$2,600k); FY2024 results (FY2023 audited); FY2025 results (FY2024 audited); AR2025 five-year summary. EBITDA is an analyst computation (operating profit plus depreciation of PPE and right-of-use assets).
Per-share data
Sources: results announcements FY2022–FY2025; AR2025. Data-quality flags: (i) the AR2025 rights-adjusted FY2021 EPS of 0.40 cents does not reconcile with FY2021 attributable profit of S$1.53M on any disclosed share base and should be treated with caution; (ii) the FY2021 dividend was declared as 0.209 cents on the pre-split base of 220,257,000 shares (≈0.070 cents split-adjusted; total S$460k); (iii) FY2024 NAV is shown on the rights-adjusted share count (1.21 cents); on the pre-rights base it was 2.09 cents (AR2024).
Margins and growth
FY2021 growth is computed against FY2020 revenue of S$34,606k (AR2024 five-year summary).
Revenue CAGR: FY2021–FY2025 (4 years): −13.2% per annum. FY2020–FY2025 (5 years): −5.6% per annum (analyst computation).
Balance sheet
Sources: FY2022–FY2025 results; AR2024 and AR2025 five-year summaries. Data-quality flags: (i) the unaudited FY2023 announcement showed cash of S$14,696k and total current assets of S$50,250k; audited figures are S$13,967k and S$49,521k; (ii) the unaudited FY2024 announcement showed total assets of S$48,328k and equity of S$12,895k; the audited FY2024 figures (S$49,423k; S$13,990k) include a S$1,095k FVOCI fair-value gain on the Pekanbaru (PPTM) stake; (iii) goodwill and intangibles are not separately presented in the condensed statements and appear immaterial; (iv) negative net debt denotes a net cash position.
Interim balance sheet update (30 June 2026, unaudited, 1H2026 results): cash S$6,809k; contract assets S$11,056k; total assets S$28,248k; borrowings S$7,755k (current S$3,806k; non-current S$3,949k); lease liabilities S$342k; equity attributable S$2,826k; total equity S$3,181k; net current assets S$2,927k; group NAV 0.25 cents per share; D/E 2.55x.
Cash flow
Sources: FY2022 results (FY2021); FY2023 results (FY2022); FY2024 results (FY2023 audited OCF of −S$4,283k; the unaudited FY2023 announcement showed −S$4,170k); FY2025 results. FY2023 equity injections comprise S$729k into the Tanah Merah JV and S$219k into PPTM. FY2025 director loans are shown gross; S$120k of prior advances was repaid. The FY2025 rights proceeds shown are cash proceeds; total net share-capital increase was S$3,934k because S$1.78M was set off against sums owed to the CEO.
1H2026 cash flow: operating cash inflow S$3,363k, driven by S$7,063k of contract-asset collections; capex S$54k; net borrowings repaid S$2,809k; director loans received S$2,000k; cash and cash equivalents S$5,922k at period end (1H2026 results).
Key ratios
Methodology (analyst computations unless noted): ROE uses average attributable equity (FY2020 opening equity S$17,079k). Company-reported ROE is from AR2024; the company computed FY2024 ROE on unaudited year-end equity, and no FY2025 ROE was published (shown as 0 = not disclosed). ROA uses total net profit and average total assets (FY2020 total assets S$37,464k). ROIC = operating profit × (1 − effective tax rate) ÷ year-end invested capital (equity + borrowings + leases − cash); no tax shield is applied in loss years. D/E: the AR2025 gearing ratio of 1.74x matches this computation, but the FY2025 results announcement narrative cited 1.2x — an unexplained internal inconsistency in the filings. Net debt/EBITDA: the Group was net cash in FY2021–FY2023 (net cash/EBITDA of 4.2x, 2.4x and 0.6x respectively); the ratio is not meaningful for FY2024–FY2025 because EBITDA was negative. Days are year-end balances over annual revenue or cost of sales × 365.
Commentary on trends, inflections and drivers
FY2021–FY2023 — growth on the back of PUB wins. Revenue rose from S$45.6M to a record S$66.9M as the Group executed TSDP, DTSS2 and then C22C. FY2022 was the margin peak (gross margin 20.2%). Pandemic-delayed Indonesian projects resumed that year, and Indonesia contributed 60.7% of revenue at higher margins (FY2022 results). In FY2023 Singapore's share jumped to 74.9%, and gross margin fell 6.3 percentage points. The FY2023 results attributed the fall partly to higher financing costs from rising interest rates.
Working-capital inflection (FY2023). Contract assets more than doubled to S$27.1M as completed but uncertified PUB work accumulated. Operating cash flow turned negative (−S$4.3M), and the Group drew down S$12.7M of revolving credit. Gearing rose from 0.22x to 0.52x. This was the first visible sign of the liquidity strain that followed.
FY2024 — the profitability break. Revenue fell 20.8%, and the Group booked a S$1.36M gross loss as budgets on the "Ongoing Projects" (C22C and DTSS2) were revised for prolonged construction, supply-chain disruption, and higher materials, manpower and finance costs (FY2024 profit guidance, Feb 2025). 2H2024 alone showed a 24.3% gross loss margin. Operating cash outflow reached S$10.0M. Borrowings rose to S$15.6M, all current, after a covenant breach required reclassification. The S$1.3M FY2023 dividend paid in FY2024 compounded the cash drain.
FY2025 — shrinking and recapitalising. Revenue halved to S$25.9M as the Singapore projects neared completion. The FY2025 gross loss margin (6.5%) was smaller in absolute terms than in 2H2024, but finance costs quadrupled to S$1.07M (bank, third-party and 12% director loans). The JV share of loss widened to S$0.62M on lower Hutan Kota water volumes. An IDR-driven S$1.47M translation loss pushed total comprehensive loss to S$10.8M. The S$3.8M rights issue only partially offset this. Equity halved to S$7.2M.
1H2026 — cash positive, equity near exhaustion. Collection of contract assets (−S$7.6M) generated a S$3.4M operating cash inflow, and borrowings were cut to S$7.8M. G&A fell 27.8% on lower headcount and dormitory costs. However, revenue fell another 51.8% to S$7.7M, gross loss widened to 7.4%, and attributable equity fell to S$2.8M. Net current assets fell to S$2.9M. The Board's going-concern assessment relies on expected project cash flows, receivable collections, ongoing lender discussions, cost cuts and "continued financial support from the Group's controlling shareholder where required" (1H2026 results, note 1).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Definition | Principal entities |
|---|---|---|
TSEPC | Total solutions with engineering, procurement and construction services for water and wastewater management | Memiontec Pte Ltd (Singapore); PT Memiontec Indonesia |
OMS | Operations and preventive/corrective maintenance services for water and wastewater plants | Memiontec Pte Ltd; PTMI |
SDS | Sales and distribution of water treatment systems, and trading | PTMI / PTMP (Indonesia); MIT Water (PRC) |
SOW | Sale of water and other recurring revenue under long-term concession arrangements | PTMI / PT Memiontec Bakti Bali (Nusa Dua BOOT, 80%) |
Segment revenue (SGD K)
| Segment revenue (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
TSEPC revenue (SGD K) | 41,604 | 39,051 | 63,634 | 49,682 | 21,753 |
OMS revenue (SGD K) | 3,371 | 2,785 | 2,349 | 1,640 | 1,507 |
SDS revenue (SGD K) | 456 | 747 | 684 | 1,465 | 2,230 |
SOW revenue (SGD K) | 214 | 204 | 183 | 127 | 458 |
Total revenue (SGD K) | 45,645 | 42,787 | 66,850 | 52,914 | 25,948 |
Results by Segment
| Segment result (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
TSEPC segment result (SGD K) | 2,930 | 4,708 | 5,636 | -5,563 | -6,125 |
OMS segment result (SGD K) | 493 | 565 | 414 | 162 | 269 |
SDS segment result (SGD K) | 209 | 314 | 207 | 397 | 348 |
SOW segment result (SGD K) | 109 | 77 | 25 | 7 | 88 |
Total segment result (SGD K) | 3,741 | 5,664 | 6,282 | -4,997 | -5,420 |
Segment margin (%)
| Segment margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
TSEPC segment margin (%) | 7.0 | 12.1 | 8.9 | -11.2 | -28.2 |
OMS segment margin (%) | 14.6 | 20.3 | 17.6 | 9.9 | 17.8 |
SDS segment margin (%) | 45.8 | 42.0 | 30.3 | 27.1 | 15.6 |
SOW segment margin (%) | 50.9 | 37.7 | 13.7 | 5.5 | 19.2 |
Segment share of revenue (%)
| Segment share of revenue (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
TSEPC share (%) | 91.1 | 91.3 | 95.2 | 93.9 | 83.8 |
OMS share (%) | 7.4 | 6.5 | 3.5 | 3.1 | 5.8 |
SDS share (%) | 1.0 | 1.7 | 1.0 | 2.8 | 8.6 |
SOW share (%) | 0.5 | 0.5 | 0.3 | 0.2 | 1.8 |
Segment YoY growth (%)
| Segment YoY growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
TSEPC growth (%) | -6.1 | 63.0 | -21.9 | -56.2 |
OMS growth (%) | -17.4 | -15.7 | -30.2 | -8.1 |
SDS growth (%) | 63.8 | -8.4 | 114.2 | 52.2 |
SOW growth (%) | -4.7 | -10.3 | -30.6 | 260.6 |
Revenue by Segment
| Segment (SGD K) | 1H2025 | 1H2026 |
|---|---|---|
TSEPC revenue (SGD K) | 14,630 | 5,489 |
OMS revenue (SGD K) | 841 | 718 |
SDS revenue (SGD K) | 322 | 814 |
SOW revenue (SGD K) | 78 | 631 |
TSEPC result (SGD K) | -2,224 | -1,851 |
OMS result (SGD K) | 195 | -6 |
SDS result (SGD K) | 20 | -129 |
SOW result (SGD K) | 14 | 201 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome statement (SGD K)
| Income statement (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (SGD K) | 45,645 | 42,787 | 66,850 | 52,914 | 25,948 |
Cost of sales (SGD K) | 39,318 | 34,154 | 57,565 | 54,274 | 27,623 |
Gross profit (SGD K) | 6,327 | 8,633 | 9,285 | -1,360 | -1,675 |
Other income (SGD K) | 560 | 231 | 323 | 475 | 265 |
General and administrative expenses (SGD K) | 4,748 | 5,364 | 5,451 | 5,475 | 5,638 |
Operating profit (SGD K) | 2,139 | 3,500 | 4,157 | -6,360 | -7,048 |
Depreciation of PPE and ROU assets (SGD K) | 318 | 357 | 351 | 431 | 413 |
EBITDA excl. JV share (SGD K) | 2,457 | 3,857 | 4,508 | -5,929 | -6,635 |
Finance costs (SGD K) | 140 | 122 | 127 | 243 | 1,070 |
Share of JV profit or loss (SGD K) | 87 | 128 | -110 | -384 | -620 |
Profit before tax (SGD K) | 2,086 | 3,506 | 3,920 | -6,987 | -8,738 |
Income tax expense (SGD K) | 545 | 936 | 683 | 401 | 544 |
Net profit total (SGD K) | 1,541 | 2,570 | 3,237 | -7,388 | -9,282 |
Net profit attributable to owners (SGD K) | 1,533 | 2,551 | 3,235 | -7,390 | -9,473 |
Per-share data
| Per-share data | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Basic EPS as reported post-split basis (S$ cents) | 0.23 | 0.39 | 0.49 | -1.12 | -0.83 |
Basic EPS rights-adjusted per AR2025 (S$ cents) | 0.40 | 0.22 | 0.28 | -0.65 | -0.83 |
Diluted EPS as reported (S$ cents) | 0.23 | 0.39 | 0.49 | -1.12 | -0.83 |
Dividend per share declared for year split-adjusted (S$ cents) | 0.070 | 0.118 | 0.196 | 0 | 0 |
NAV per share as reported at year end (S$ cents) | 2.75 | 2.92 | 3.27 | 1.21 | 0.59 |
Margin and growth metric (%)
| Margin and growth metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 13.9 | 20.2 | 13.9 | -2.6 | -6.5 |
Operating margin (%) | 4.7 | 8.2 | 6.2 | -12.0 | -27.2 |
EBITDA margin (%) | 5.4 | 9.0 | 6.7 | -11.2 | -25.6 |
Net margin attributable (%) | 3.4 | 6.0 | 4.8 | -14.0 | -36.5 |
Revenue growth YoY (%) | 31.9 | -6.3 | 56.2 | -20.8 | -51.0 |
Balance Sheet
| Balance sheet (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash and bank balances (SGD K) | 15,451 | 13,334 | 13,967 | 9,055 | 6,305 |
Trade and other receivables (SGD K) | 8,495 | 8,020 | 5,857 | 6,755 | 6,459 |
Contract assets (SGD K) | 6,009 | 11,756 | 27,132 | 26,794 | 18,630 |
Inventories (SGD K) | 146 | 32 | 2,565 | 139 | 31 |
Total current assets (SGD K) | 30,101 | 33,142 | 49,521 | 42,743 | 31,425 |
Total non-current assets (SGD K) | 5,375 | 5,091 | 5,681 | 6,680 | 5,284 |
Total assets (SGD K) | 35,476 | 38,233 | 55,202 | 49,423 | 36,709 |
Trade and other payables (SGD K) | 10,312 | 12,892 | 19,794 | 16,379 | 14,843 |
Short-term borrowings (SGD K) | 1,155 | 1,431 | 9,726 | 15,574 | 9,360 |
Long-term borrowings (SGD K) | 3,566 | 2,387 | 1,182 | 0 | 2,678 |
Total borrowings (SGD K) | 4,721 | 3,818 | 10,908 | 15,574 | 12,038 |
Lease liabilities (SGD K) | 505 | 443 | 336 | 757 | 438 |
Net debt incl. leases (SGD K) | -10,225 | -9,073 | -2,723 | 7,276 | 6,171 |
Total current liabilities (SGD K) | 13,048 | 15,890 | 31,818 | 34,531 | 26,091 |
Total non-current liabilities (SGD K) | 4,204 | 2,976 | 1,722 | 902 | 3,447 |
Total liabilities (SGD K) | 17,252 | 18,866 | 33,540 | 35,433 | 29,538 |
Share capital (SGD K) | 12,092 | 12,092 | 12,092 | 12,092 | 16,026 |
Equity attributable to owners (SGD K) | 18,174 | 19,307 | 21,602 | 13,821 | 6,791 |
Total equity (SGD K) | 18,224 | 19,367 | 21,662 | 13,990 | 7,171 |
Net current assets (SGD K) | 17,053 | 17,252 | 17,703 | 8,212 | 5,334 |
Cash flow (SGD K)
| Cash flow (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (SGD K) | 2,959 | 346 | -4,283 | -9,964 | -1,757 |
Capex purchase of PPE (SGD K) | 365 | 91 | 68 | 44 | 11 |
Free cash flow (SGD K) | 2,594 | 255 | -4,351 | -10,008 | -1,768 |
Equity injections into BOOT investees (SGD K) | 560 | 112 | 948 | 0 | 68 |
Dividends paid (SGD K) | 407 | 460 | 780 | 1,295 | 0 |
Share buybacks (SGD K) | 0 | 0 | 0 | 0 | 0 |
Proceeds from bank borrowings (SGD K) | 900 | 250 | 12,662 | 30,093 | 11,987 |
Repayments of borrowings (SGD K) | 1,216 | 1,153 | 5,572 | 25,449 | 15,527 |
Loans and advances from directors (SGD K) | 0 | 0 | 0 | 2,120 | 2,000 |
Proceeds from rights cum warrants issue (SGD K) | 0 | 0 | 0 | 0 | 2,154 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average attributable equity (%) | 8.7 | 13.6 | 15.8 | -41.7 | -91.9 |
ROE as reported by company (%) | 8.4 | 13.2 | 15.0 | -58.1 | 0 |
ROA on average total assets (%) | 4.2 | 7.0 | 6.9 | -14.1 | -21.6 |
ROIC analyst estimate (%) | 19.8 | 24.9 | 18.1 | -29.9 | -52.8 |
Current ratio (x) | 2.31 | 2.09 | 1.56 | 1.24 | 1.20 |
Debt to equity incl. leases (x) | 0.29 | 0.22 | 0.52 | 1.17 | 1.74 |
Interest coverage EBIT to finance costs (x) | 15.3 | 28.7 | 32.7 | -26.2 | -6.6 |
Asset turnover (x) | 1.25 | 1.16 | 1.43 | 1.01 | 0.60 |
DSO incl. contract assets (days) | 116 | 169 | 180 | 231 | 353 |
Inventory days (days) | 1 | 0 | 16 | 1 | 0 |
DPO (days) | 96 | 138 | 126 | 110 | 196 |
Cash conversion cycle proxy (days) | 21 | 31 | 70 | 122 | 157 |
Geographic revenue (SGD K)
| Geographic revenue (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Singapore revenue (SGD K) | 31,619 | 16,800 | 50,044 | 34,559 | 10,395 |
Indonesia revenue (SGD K) | 13,985 | 25,971 | 16,795 | 18,355 | 15,553 |
China revenue (SGD K) | 41 | 16 | 11 | 0 | 0 |
Revenue by Region (%) and Region Margins & Growth (%)
| Geographic metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Singapore share of revenue (%) | 69.3 | 39.3 | 74.9 | 65.3 | 40.1 |
Indonesia share of revenue (%) | 30.6 | 60.7 | 25.1 | 34.7 | 59.9 |
Singapore revenue growth (%) | 0 | -46.9 | 197.9 | -30.9 | -69.9 |
Indonesia revenue growth (%) | 0 | 85.7 | -35.3 | 9.3 | -15.3 |
Geographic revenue (SGD K) (1H2024–1H2026)
| Geographic revenue (SGD K) | 1H2024 | 1H2025 | 1H2026 |
|---|---|---|---|
Singapore revenue (SGD K) | 22,926 | 5,492 | 3,933 |
Indonesia revenue (SGD K) | 7,119 | 10,379 | 3,719 |
TSEPC revenue by country (SGD Mn)
| TSEPC revenue by country (SGD Mn) | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
TSEPC Singapore (SGD Mn) | 13.0 | 48.3 | 32.9 |
TSEPC Indonesia (SGD Mn) | 26.0 | 15.2 | 16.7 |
Non-current segment assets (SGD K)
| Non-current segment assets (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Singapore non-current assets (SGD K) | 763 | 707 | 538 | 564 | 293 |
Indonesia non-current assets (SGD K) | 4,470 | 4,303 | 5,068 | 5,990 | 4,873 |
China non-current assets (SGD K) | 81 | 16 | 11 | 5 | 1 |
Share Price History
| Date | Price (SGD) | Context | Source |
|---|---|---|---|
5 Mar 2020 | 0.225 | IPO placement price (pre-split; ≈0.075 split-adjusted) | Placement results |
28 Apr 2021 | 0.23 | Close after DTSS2 award | The Edge Singapore |
3 Aug 2021 | 0.24 | Start of the surge flagged by RegCo | SGX RegCo |
12 Jan 2022 | 0.95 | Peak flagged by RegCo (pre-split; ≈0.317 split-adjusted) | SGX RegCo |
May 2025 | 0.009 | Rights issue price | Rights terms |
1 Aug 2025 | 0.013 | Close before 1H2025 loss guidance | The Edge Singapore |
9 Oct 2026 | 0.009 | Latest close; 52-week range 0.006–0.014 | StockAnalysis |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Shares outstanding | ≈1,146.1 M | 30 Jun 2026 |
Market capitalisation | ≈S$10.3 M | StockAnalysis |
Enterprise value | ≈S$11.6 M | Market cap + borrowings S$7.76M + leases S$0.34M − cash S$6.81M (30 Jun 2026) |
P/E (TTM) | n.m. (loss-making) | TTM net loss ≈S$8.75M attributable (StockAnalysis) |
EV/EBITDA | n.m. (negative EBITDA) | — |
EV/Sales (TTM) | ≈0.65x | TTM revenue S$17.73M (2H2025 S$10.08M + 1H2026 S$7.65M) |
P/B | ≈3.6x | Attributable equity S$2.83M (30 Jun 2026) |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total dividend declared for year (SGD K) | 460 | 780 | 1,295 | 0 | 0 |
DPS split-adjusted (S$ cents) | 0.070 | 0.118 | 0.196 | 0 | 0 |
Payout ratio of attributable profit (%) | 30.0 | 30.6 | 40.0 | 0 | 0 |
Share count (millions of shares)
| Share count (millions of shares) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Shares in issue at year end split-adjusted (M) | 660.771 | 660.771 | 660.771 | 660.771 | 1,142.964 |
Warrants outstanding at year end (M) | 0 | 0 | 0 | 0 | 663.143 |
Capital Instruments
| Instrument | Due within 1 year (SGD K) | Due after 1 year (SGD K) |
|---|---|---|
Invoice financing | 893 | 0 |
Term loans | 1,401 | 3,949 |
Short-term borrowing (third-party private lender) | 1,512 | 0 |
Revolving credit | 0 | 0 |
Lease liabilities | 225 | 117 |
Total | 4,031 | 4,066 |
Analyst Conclusions
Management guidance
No quantitative guidance. The latest commentary (1H2026 results, 13 Aug 2026) says the Group will:
-
pursue Singapore public and private membrane and MEICA work with stricter risk and return discipline;
-
pursue larger Indonesian EPC opportunities and new BOOTs through partnerships;
-
explore investment, JV and tendering opportunities in Vietnam;
-
operate "with prudence," monitoring IDR volatility closely.
AR2025 states that management aims to "stabilise and recover" through better project execution, cost efficiency, collection of final accounts and VOs, and equity and debt fundraising.
Consensus growth expectations
None available (no sell-side coverage).
Bull case (grounded in the data)
-
VO and final-account recovery. VO claims on C22C and other delayed projects are excluded from both the accounts and management's cash-flow projections. Successful certification would fall directly to gross profit and cash. Against a S$10M market cap, even low-single-digit-million recoveries would be material.
-
Recurring income inflection. SOW was the only meaningfully profitable segment in 1H2026 (S$201k on S$631k). Bali (80%) reaching commercial operation and Tanah Merah (42%) beginning sales could make concessions a stable earnings floor, with 15–25-year duration.
-
Cost base reset and cash stabilisation. G&A fell 27.8% in 1H2026, operating cash flow turned positive (+S$3.4M), and borrowings fell 37.6% in six months (S$12.0M to S$7.8M). Once the loss-making Singapore contracts roll off, the remaining business could break even at lower revenue.
Bear case (grounded in the data)
-
Equity is nearly exhausted. S$2.8M of attributable equity after a S$3.2M half-year loss leaves essentially no buffer. Another loss half-year at the 1H2026 run rate would wipe out book value, making further dilutive equity or deeper founder support likely.
-
The franchise is shrinking. Revenue has fallen for five consecutive half-years to S$7.7M (1H2026). The order book was just S$15.9M at end-2025, with no major award since 2022. A constrained balance sheet limits the bonding capacity needed to win large PUB tenders.
-
Governance and funding concentration. The CEO is simultaneously controlling shareholder, principal lender (12% loans), personal guarantor and the subject (with the former MD) of an unresolved CAD–MAS securities investigation. An adverse outcome could impair key relationships with PUB, banks and Indonesian SOE partners.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | Why it matters |
|---|---|---|
| Certification and collection of VO claims and final accounts on C22C and DTSS2 | Ongoing; FY2026 results | Primary source of upside cash and margin |
| Bali BOOT commercial operation date announcement | — | Converts testing revenue into contracted SOW |
| Tanah Merah BOOT operating disclosure and first share of results | FY2026–FY2027 | Recurring income contribution |
| New contract wins (PUB, Indonesian EPC, Vietnam) | Any time | Order book currently below one year of revenue |
| Covenant waiver renewals; refinancing of the third-party private loan | FY2026 year end | Going-concern pivot |
| FY2026 results and audit opinion (any going-concern emphasis or modification) | By ~1 Mar 2027 (results); ~Apr 2027 (AR) | Audit treatment of liquidity |
| Further equity fundraising and warrant exercise | Ongoing | Dilution vs balance-sheet repair |
| CAD–MAS investigation outcome | Unknown | Key-person and reputational risk |
| IDR/SGD exchange rate | Continuous | Translation losses on Indonesian net assets |
Concluding analyst verdict
Memiontec shows how a technically capable specialist contractor can be undone by a few large fixed-price contracts. Between 2019 and 2022 the Group won the most prestigious work in its history — TSDP, DTSS2 and the S$56.6M C22C MBR package — and FY2023 brought record revenue of S$66.9M and a 15.8% return on equity. Those same contracts, signed before post-pandemic cost inflation, then consumed most of the Group's capital. Attributable equity fell from S$21.6M to S$2.8M in thirty months. Covenants broke, a rights issue diluted holders by two-thirds, and the founder became the Group's lender of last resort at 12%.
The positive signs are real but early. The worst Singapore contracts are substantially complete. Collections are converting contract assets into cash, producing a S$3.4M operating inflow in 1H2026. Overheads are falling. The Indonesian concession portfolio — Bali at 80%, Tanah Merah at 42%, plus Hutan Kota, Waduk Pluit and Pekanbaru — is finally contributing recurring water sales. Unrecognised VO claims are a free option on the upside.
The negatives are larger in near-term scale. The revenue base has collapsed to an annualised S$15–18M, and the order book is thin. Equity is close to zero, and management openly relies on lender waivers and controlling-shareholder support. An unresolved securities investigation also hangs over the two founders.
At ≈S$10M market value and ≈3.6x book, the equity is priced as an option on a successful recovery rather than as a going-concern earnings stream. The next twelve months — VO certification, Bali's commercial start, covenant renewal and the FY2026 audit opinion — will decide whether Memiontec stabilises as a small concession-plus-services water platform or needs another recapitalisation. Institutional mandates requiring balance-sheet resilience or clean governance should treat it as uninvestable until those catalysts resolve.
Data integrity statement: all figures are drawn from the named filings and sources. Where filings conflict (FY2022 and FY2023 unaudited vs audited; FY2023 segment notes; FY2025 D/E; PPTM injection amounts; concession capacities; FY2024 local procurement), both values are noted.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | First appointed | Last re-elected | Background and education |
|---|---|---|---|---|
Hor Siew Fu | Independent Non-Executive Chairman (Chairman since 22 Jul 2024) | 30 Dec 2019 | 25 Apr 2025 | Former CFO of Albedo Ltd (2014–2016) and CosmoSteel Holdings (2007–2013); Deutz MWM Asia Pacific (1984–1996); Keppel group (1976–1984). B.Acc (University of Singapore, 1976); MBA (Macquarie, 1994); FCA (ISCA); FCCA. ID of other SGX companies (per AR2024). |
Tay Kiat Seng | Executive Director and CEO; co-founder; controlling shareholder | 6 Mar 2013 | 29 Apr 2022 (seeking re-election 30 Apr 2026) | Co-founded the business in 1992. Previously senior manager at Watermac Engineering (2 years) and design engineer on MEMCOR membranes at Memtec Ltd, Australia (2 years). B.Eng (Mechanical), University of Strathclyde (1988); Stanford Scale-Up SG programme (2021). |
Ling Chung Yee, Roy | Independent Non-Executive Director | 22 Jul 2024 | 25 Apr 2025 (seeking re-election 30 Apr 2026) | 20+ years of investment banking (JPMorgan, Lehman Brothers, Goldman Sachs, Salomon Smith Barney); CEO and founder of FollowTrade; adjunct at NUS/SMU/SUSS; ID of VinFast Auto and other listed companies (per AR2024). Global EMBA (INSEAD); BBA (Hons) (NUS). |
Chua Siong Kiat | Non-Executive Non-Independent Director | 26 Apr 2025 | — | Group CFO from 28 Apr 2023 to 25 Apr 2025; founder of Lighthouse Business Consulting (2017); ID on three other SGX companies. FCCA, FCA (Singapore), CIA, CVA, SID Senior Accredited Director; MBA/DIC (Imperial College London). |
Board of Directors — Soelistyo Dewi Soegiharto
| Name | Former role | Tenure | Exit |
|---|---|---|---|
Soelistyo Dewi Soegiharto | Managing Director; co-founder; substantial shareholder; spouse of the CEO | 6 Mar 2013 – 25 Apr 2025 | Retired at the 2025 AGM; remains director of Memiontec Pte Ltd and other subsidiaries |
Yap Chee Wee | Independent Director (founder of Fleur Capital) | 1 Sep 2023 – 25 Apr 2025 | Retired at the 2025 AGM |
Board of Directors — Toh Kai En
| Name | Role | Since | Background |
|---|---|---|---|
Toh Kai En | Financial Controller (head of Group finance) | 25 Apr 2025 | Joined 2021 as Group Accountant; Group Finance Manager from May 2023; formerly Baker Tilly TFW (2017–2021); CA (Singapore); B.Acc (NTU, 2017) |
Lim Wei Kuan | Director, Memiontec Pte Ltd | Director since Dec 2019 (with Group since 2006) | B.Eng (Chemical), University of Malaya (2006); responsible for Singapore design, sales, execution and P&L |
Soelistyo Dewi Soegiharto | Director, Memiontec Pte Ltd | Co-founder (1992) | B.Eng (Chemical), UNSW (1991) |
Irawati Tan | Director, PT Memiontec Indonesia | Joined 2009 | Formerly with the Astel Group (budget/finance controller; procurement manager); B.Acc, Bina Nusantara University (2004) |
Directors' Remuneration
| Compensation item (SGD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Directors' remuneration in G&A (SGD K) | 802 | 1,088 | 965 | 528 | 638 |
Directors' fees (SGD K) | 148 | 150 | 139 | 135 | 145 |
Major Shareholders
| Holder | Shares | % | Date / basis | Source |
|---|---|---|---|---|
Tay Kiat Seng (CEO), direct | 296,676,888 | 44.9% of 660,771,000 | 31 Aug 2023 (pre-rights) | MarketScreener |
Soelistyo Dewi Soegiharto | 104,425,239 | 15.8% of 660,771,000 (analyst computation) | Pre-rights | Simply Wall St shareholder list |
Unity Strength Pte. Ltd. (CEO is a director; CEO increased his stake in this entity per company disclosure) | 79,369,662 | 12.0% of 660,771,000 (analyst computation) | Pre-rights | Simply Wall St; TipRanks news headline |
Khee Seng Yeo | 30,000,000 | n/v | n/v | Simply Wall St |
Zhi Ng | 20,995,500 | n/v | n/v | Simply Wall St |
Futu Singapore Pte. Ltd. (only identifiable institution) | 1,661,300 | ≈0.15% | n/v | Simply Wall St |
Competitive Landscape
Competitors by Segment
| Segment / market | Competitor | Positioning vs Memiontec |
|---|---|---|
Singapore PUB water/wastewater EPC and MEICA | Koh Brothers Eco Engineering (SGX Catalist: 5HV) | Larger civil/water EPC contractor; involved at Tuas Water Reclamation Plant; much larger revenue base |
Singapore PUB EPC | Keppel (Keppel Infrastructure / Keppel Seghers) | Integrated developer-operator of desalination and NEWater; vastly larger balance sheet |
Singapore/regional water operations | Sembcorp Industries (water business) | Utility-scale water concessions and EPC; investment-grade scale |
Singapore membrane plant EPC (legacy) | Hyflux (in liquidation; no longer a competitor) | Its exit reduced local competition for membrane packages |
Singapore/Malaysia/PRC/Vietnam water EPC and O&M | Darco Water Technologies (SGX: BLR) | Closest listed micro-cap peer; industrial water EPC plus O&M; Vietnam water concession (Darco Ba Lai) |
Global water EPC/technology | Veolia; SUEZ | Technology and O&M leaders on large municipal contracts |
Indonesian state-owned EPC | PT Wijaya Karya (WIKA); PT Adhi Karya; PT PP (also a partner) | Dominant in large public water infrastructure; Memiontec typically partners with these SOEs |
Indonesian water concessions | Moya Indonesia group (PT Aetra Air Jakarta and others) | Larger private water concession operator in Jakarta and Indonesia |
PRC/Asia municipal water | China Everbright Water; SIIC Environment | Large Chinese municipal water operators; not present in Memiontec's core markets |
Industrial water treatment | Kurita (Japan); Toray-linked engineering units | Industrial water chemistry and membranes; SDS-adjacent competition |
Peer Comparison FY2025
| Metric | Memiontec (FY2025) | Darco Water Technologies (FY2025) | Koh Brothers Eco Engineering | Koh Brothers Group (parent of KBE, FY2025) |
|---|---|---|---|---|
Revenue (SGD Mn) | 25.9 | 51.4 | — | 329.4 |
Revenue growth (%) | -51.0 | -13.1 | +68 (1H2025 YoY) | +38.2 |
Gross margin (%) | -6.5 | 12.3 | 12.4 (1H2025: S$13.9M on S$111.9M) | 11.9 |
Operating margin (%) | -27.2 | -10.0 (operating income −S$5.13M per S&P Global data) | n/v | n/v |
Net income attributable (SGD Mn) | -9.5 | -4.85 | 3.04 (1H2025) | 18.6 |
Market capitalisation (SGD Mn) | ≈10.3 (Oct 2026) | ≈7.5 (Simply Wall St, date n/v) | n/v | n/v |



